Swiss pharma company Roche is buying Flatiron Health for $1.9 billion

 Roche, the global pharmaceutical company from Switzerland today announced it will scoop up Flatiron Health, a startup analyzing real-time oncology data to help cancer patients and doctors in a $1.9 billion deal. Flatiron has also confirmed the deal to TechCrunch. Two years ago, Roche led a $175 million deal in the startup at a $1.2 billion valuation. At the time of the deal, Roche agreed… Read More
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.